Mu-selective, but not non-selective, opioid receptor antagonism reduces L-DOPA induced dyskinesia in the MPTP macaque model of Parkinson's disease

被引：0
|
作者：
Fox, S. H.
Koprich, J. B.
Johnston, T. H.
Goodman, A.
Le Bourdonnec, B.
Dolle, R. E.
DeHaven, R. N.
DeHaven, D. L.
Little, P. J.
Brotchie, J. M.
机构：
来源：
MOVEMENT DISORDERS | 2010年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [31] Distinct Effects of Intranigral L-DOPA Infusion in the MPTP Rat Model of Parkinson's Disease
    Reksidler, Angela B.
    Lima, Marcelo M. S.
    Dombrowski, Patricia A.
    Barnabe, Gabriela F.
    Andersen, Monica L.
    Tufik, Sergio
    Vital, Maria A. B. F.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2009, (73): : 259 - 268
  • [32] Determination of plasma, brain and cerebrospinal fluid levels of L-DOPA in the MPTP-lesioned cynomolgus macaque model of Parkinson's disease
    Huot, P.
    Johnston, T. H.
    Koprich, J. B.
    Fox, S. H.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2012, 27 : S41 - S41
  • [33] The histamine H2 receptor antagonist, famotidine, reduces L-dopa-induced motor complications in the MPTP-lesioned macaque model of Parkinson's disease
    Fox, S. H.
    Johnston, T. H.
    Vandermeij, A.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2009, 24 : S351 - S352
  • [34] Selective M4 antagonism potentiates L-DOPA-induced dyskinesia in MPTP-treated common marmosets
    Klisko, D.
    Fisher, R.
    Lincoln, L.
    Jenner, P.
    Rose, S.
    MOVEMENT DISORDERS, 2016, 31 : S607 - S607
  • [35] Dopamine D2 receptor gene polymorphisms and L-dopa induced psychosis and dyskinesia in Parkinson's disease
    Kaiser, R
    Hofer, A
    Grapengiesser, A
    Gasser, T
    Roots, I
    Kupsch, A
    Brockmöller, J
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 815 - 815
  • [36] Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia
    Ravenscroft, P
    Chalon, S
    Brotchie, JM
    Crossman, AR
    EXPERIMENTAL NEUROLOGY, 2004, 185 (01) : 36 - 46
  • [37] Effect of L-DOPA in a rat model of Parkinson's disease induced by the selective proteasome inhibitor lactacystin: behavioral and biochemical studies
    Konieczny, Jolanta
    Lenda, Tomasz
    Czarnecka, Anna
    Antkiewicz-Michaluk, Lucyna
    Zapala, Malgorzata
    Lorenc-Koci, Elzbieta
    PHARMACOLOGICAL REPORTS, 2012, 64 (02) : 466 - 467
  • [38] Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson's disease
    Gonzalez-Aparicio, Ramiro
    Moratalla, Rosario
    NEUROBIOLOGY OF DISEASE, 2014, 62 : 416 - 425
  • [39] Effect of L-DOPA in a rat model of Parkinson’s disease induced by the selective proteasome inhibitor lactacystin: behavioral and biochemical studies
    Jolanta Konieczny
    Tomasz Lenda
    Anna Czarnecka
    Lucyna Antkiewicz-Michaluk
    Małgorzata Zapała
    Elżbieta Lorenc-Koci
    Pharmacological Reports, 2012, 64 (2) : 466 - 467
  • [40] Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease
    Fox, S
    Silverdale, M
    Kellett, M
    Davies, R
    Steiger, M
    Fletcher, N
    Crossman, A
    Brotchie, J
    MOVEMENT DISORDERS, 2004, 19 (05) : 554 - 560
12345